TEST BANK FOR LEHNE'S
PHARMACOTHERAPEUTICS FOR ADVANCED
PRACTICE NURSES AND PHYSICIAN
ASSISTANTS 3RD EDITION COMPLETE
CHAPTERS 1 TO 89 WITH VERIFIED
QUESTIONS ANSWERS AND RATIONALES
LATEST 2026 A PLUS EXAM GUIDE
• This question test bank mirrors the scope and clinical depth of Lehne's
Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 3rd
Edition — covering Chapters 1 through 89 with verified answers and EXPERT
RATIONALE to maximize exam readiness.
• Use this material by attempting each question independently before reviewing the
correct answer and EXPERT RATIONALE, focusing on weak areas by topic block for
targeted, high-yield preparation.
TEST BANK — LEHNE'S PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
NURSES AND PHYSICIAN ASSISTANTS, 3RD EDITION
Questions with Answers and EXPERT RATIONALE | Chapters 1–89
UNIT I: BASIC PRINCIPLES OF PHARMACOLOGY
1. A drug that binds to a receptor and produces a maximal biological response
is best described as which of the following?
A. Antagonist
B. Partial agonist
C. Inverse agonist
D. Competitive inhibitor
E. Full agonist
,Correct Answer: E. Full agonist
EXPERT RATIONALE: A full agonist binds to a receptor and activates it to produce
the maximum possible response. Partial agonists produce a submaximal response.
Antagonists bind without producing a response and block agonist activity.
2. Which pharmacokinetic process refers to the movement of a drug from its
site of administration into the systemic circulation?
A. Distribution
B. Metabolism
C. Excretion
D. Absorption
E. Elimination
Correct Answer: D. Absorption
EXPERT RATIONALE: Absorption is the transfer of a drug from its administration
site into the bloodstream. Distribution refers to drug movement into tissues.
Metabolism and excretion are elimination processes.
3. A drug has a half-life of 8 hours. Approximately how long will it take to
reach steady-state plasma concentration with regular dosing?
A. 8 hours
B. 16 hours
C. 24 hours
D. 32 hours
E. 40 hours
Correct Answer: E. 40 hours
,EXPERT RATIONALE: Steady state is reached after approximately 4–5 half-lives.
With a half-life of 8 hours, steady state is reached in approximately 32–40 hours (5 ×
8 = 40 hours).
4. Which of the following best describes the volume of distribution (Vd) of a
drug?
A. The actual volume of blood in which a drug is dissolved
B. The rate at which a drug is eliminated from the body
C. A theoretical volume that relates total drug in the body to plasma concentration
D. The proportion of the drug that reaches systemic circulation
E. The volume of urine produced per unit of time
Correct Answer: C. A theoretical volume that relates total drug in the body to
plasma concentration
EXPERT RATIONALE: Vd is a calculated parameter reflecting how extensively a drug
distributes into tissues versus remaining in plasma. A large Vd indicates wide tissue
distribution; a small Vd suggests the drug stays in plasma.
5. A patient is prescribed a drug with high first-pass metabolism. Which route
of administration would best avoid this effect?
A. Oral
B. Rectal (partial)
C. Sublingual
D. Enteral via NG tube
E. Buccal
Correct Answer: C. Sublingual
, EXPERT RATIONALE: Sublingual administration allows drugs to be absorbed
directly into systemic circulation via the sublingual veins, bypassing the hepatic
portal system and thus avoiding first-pass metabolism entirely.
6. Which of the following cytochrome P450 enzymes is responsible for
metabolizing the greatest number of drugs?
A. CYP1A2
B. CYP2C9
C. CYP2D6
D. CYP3A4
E. CYP2E1
Correct Answer: D. CYP3A4
EXPERT RATIONALE: CYP3A4 is the most abundant CYP enzyme in the liver and
intestine, and it metabolizes approximately 50% of all clinically used drugs, making
it the most clinically significant isoenzyme.
7. A patient taking rifampin (a CYP3A4 inducer) is started on oral
contraceptives. The nurse practitioner should anticipate which of the
following outcomes?
A. Increased contraceptive efficacy
B. Decreased rifampin levels
C. Reduced contraceptive plasma levels and potential failure
D. Elevated estrogen levels
E. No clinically significant interaction
Correct Answer: C. Reduced contraceptive plasma levels and potential failure
PHARMACOTHERAPEUTICS FOR ADVANCED
PRACTICE NURSES AND PHYSICIAN
ASSISTANTS 3RD EDITION COMPLETE
CHAPTERS 1 TO 89 WITH VERIFIED
QUESTIONS ANSWERS AND RATIONALES
LATEST 2026 A PLUS EXAM GUIDE
• This question test bank mirrors the scope and clinical depth of Lehne's
Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 3rd
Edition — covering Chapters 1 through 89 with verified answers and EXPERT
RATIONALE to maximize exam readiness.
• Use this material by attempting each question independently before reviewing the
correct answer and EXPERT RATIONALE, focusing on weak areas by topic block for
targeted, high-yield preparation.
TEST BANK — LEHNE'S PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE
NURSES AND PHYSICIAN ASSISTANTS, 3RD EDITION
Questions with Answers and EXPERT RATIONALE | Chapters 1–89
UNIT I: BASIC PRINCIPLES OF PHARMACOLOGY
1. A drug that binds to a receptor and produces a maximal biological response
is best described as which of the following?
A. Antagonist
B. Partial agonist
C. Inverse agonist
D. Competitive inhibitor
E. Full agonist
,Correct Answer: E. Full agonist
EXPERT RATIONALE: A full agonist binds to a receptor and activates it to produce
the maximum possible response. Partial agonists produce a submaximal response.
Antagonists bind without producing a response and block agonist activity.
2. Which pharmacokinetic process refers to the movement of a drug from its
site of administration into the systemic circulation?
A. Distribution
B. Metabolism
C. Excretion
D. Absorption
E. Elimination
Correct Answer: D. Absorption
EXPERT RATIONALE: Absorption is the transfer of a drug from its administration
site into the bloodstream. Distribution refers to drug movement into tissues.
Metabolism and excretion are elimination processes.
3. A drug has a half-life of 8 hours. Approximately how long will it take to
reach steady-state plasma concentration with regular dosing?
A. 8 hours
B. 16 hours
C. 24 hours
D. 32 hours
E. 40 hours
Correct Answer: E. 40 hours
,EXPERT RATIONALE: Steady state is reached after approximately 4–5 half-lives.
With a half-life of 8 hours, steady state is reached in approximately 32–40 hours (5 ×
8 = 40 hours).
4. Which of the following best describes the volume of distribution (Vd) of a
drug?
A. The actual volume of blood in which a drug is dissolved
B. The rate at which a drug is eliminated from the body
C. A theoretical volume that relates total drug in the body to plasma concentration
D. The proportion of the drug that reaches systemic circulation
E. The volume of urine produced per unit of time
Correct Answer: C. A theoretical volume that relates total drug in the body to
plasma concentration
EXPERT RATIONALE: Vd is a calculated parameter reflecting how extensively a drug
distributes into tissues versus remaining in plasma. A large Vd indicates wide tissue
distribution; a small Vd suggests the drug stays in plasma.
5. A patient is prescribed a drug with high first-pass metabolism. Which route
of administration would best avoid this effect?
A. Oral
B. Rectal (partial)
C. Sublingual
D. Enteral via NG tube
E. Buccal
Correct Answer: C. Sublingual
, EXPERT RATIONALE: Sublingual administration allows drugs to be absorbed
directly into systemic circulation via the sublingual veins, bypassing the hepatic
portal system and thus avoiding first-pass metabolism entirely.
6. Which of the following cytochrome P450 enzymes is responsible for
metabolizing the greatest number of drugs?
A. CYP1A2
B. CYP2C9
C. CYP2D6
D. CYP3A4
E. CYP2E1
Correct Answer: D. CYP3A4
EXPERT RATIONALE: CYP3A4 is the most abundant CYP enzyme in the liver and
intestine, and it metabolizes approximately 50% of all clinically used drugs, making
it the most clinically significant isoenzyme.
7. A patient taking rifampin (a CYP3A4 inducer) is started on oral
contraceptives. The nurse practitioner should anticipate which of the
following outcomes?
A. Increased contraceptive efficacy
B. Decreased rifampin levels
C. Reduced contraceptive plasma levels and potential failure
D. Elevated estrogen levels
E. No clinically significant interaction
Correct Answer: C. Reduced contraceptive plasma levels and potential failure
